Article Details

Intellia Therapeutics soars 63% after its gene-editing CRISPR therapy shows success in first ...

Retrieved on: 2021-06-28 13:18:45

Tags for this article:

Click the tags to see associated articles and topics

Intellia Therapeutics soars 63% after its gene-editing CRISPR therapy shows success in first .... View article details on hiswai:

Excerpt

... much as 63% early on Mondayafter the company released promising data from its ... events and an encouraging safety profile, according to the company. ... to advance the CRISPR technology for in vivo therapeutic development.

Article found on: markets.businessinsider.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo